Jan Schmidt-Brand
Corporate Officer/Principal en BIOPRO Baden-Württemberg GmbH .
Origen de la red de primer grado Jan Schmidt-Brand.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 13 | |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jan Schmidt-Brand a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
MOLOGEN AG | Miscellaneous Commercial Services | Director of Finance/CFO | |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The private company is based in Greenford, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GlaxoWellcome /Pharmocology Unit/ | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Doctorate Degree | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Long Island University | College/University | Graduate Degree | |
HUADONG MEDICINE CO., LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Sales & Marketing | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Corporate Officer/Principal | |
RWTH Aachen University | College/University | Undergraduate Degree | |
Technical University of Berlin | College/University | Corporate Officer/Principal | |
University of Mannheim | College/University | Undergraduate Degree | |
Tsinghua University | College/University | Masters Business Admin | |
Nankai University | College/University | Doctorate Degree | |
Humboldt-Universität zu Berlin | College/University | Undergraduate Degree | |
University of Pecs | College/University | Doctorate Degree | |
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Director/Board Member | |
Otto-von-Guericke-Universität Magdeburg | College/University | Doctorate Degree | |
dievini Hopp BioTech holding GmbH & Co. KG
dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Chief Executive Officer | |
Merz Beteiligungs GmbH
Merz Beteiligungs GmbH Pharmaceuticals: MajorHealth Technology Merz GmbH & Co. KGaA was engaged in the manufacture and distribution of pharmaceutical, dental, and consumer care products. It also offered promotional items. The company was founded on May 9, 1908 and was headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Chairman | |
GEUDER AG
GEUDER AG Medical SpecialtiesHealth Technology GEUDER AG manufactures ophthalmic surgical instruments and systems. Its products include eye specula, retractors, foreign body instruments, scissors, forceps, needle holders and sterilization containers and adapters. The company was founded by Hans Geuder, Sr. in 1951 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman | |
Nuvisan GmbH
Nuvisan GmbH BiotechnologyHealth Technology Nuvisan GmbH operates as an independent research institute. It performs legally prescribed drug studies and specializes in bioanalytical analysis, pharmaceutical analysis, quality control, stability testing and test sample production, as well as clinical drug development. The company was founded in 1979 and is headquartered in Neu-Ulm, Germany. | Biotechnology | Corporate Officer/Principal | |
Joimax GmbH
Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member | |
dievini Verwaltungs GmbH | Chief Executive Officer | ||
CologneInvest GmbH
CologneInvest GmbH Investment ManagersFinance CologneInvest GmbH provides venture capital and coaching services. It offers private equity, business angel/coaching, networking contacts, and shareholder capital. The company is headquartered in Cologne, Germany. | Investment Managers | Chief Executive Officer | |
Molecular Health GmbH
Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
Wilex, Inc.
Wilex, Inc. Medical/Nursing ServicesHealth Services Part of Nuclea Biotechnologies, Inc., Wilex, Inc. develops medical diagnostic tests. The private company is based in Cambridge, MA. The CEOs of the company are Thomas Borcholte, Olaf G. Wilhelm. Wilex was acquired by Nuclea Biotechnologies, Inc. from Heidelberg Pharma AG on September 06, 2013. | Medical/Nursing Services | Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
Novaliq GmbH
Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Director/Board Member | |
dievini patch Beteiligungs GmbH
dievini patch Beteiligungs GmbH Financial ConglomeratesFinance dievini patch Beteiligungs GmbH provides investment services. The company is headquartered in Andernach, Germany. | Financial Conglomerates | Chief Executive Officer | |
Optimapharm doo
Optimapharm doo Miscellaneous Commercial ServicesCommercial Services Optimapharm doo engages in the data and project management services. It also offers monitoring and medical writing services. The company was founded by Gordana Greguric Cicak and Igor Cicak on May 11, 2005 and is headquartered in Zagreb, Croatia. | Miscellaneous Commercial Services | Director of Finance/CFO | |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Real Estate Development | Chief Executive Officer | |
Hmm Consulting | Chief Executive Officer | ||
IMMATICS N.V. | Biotechnology | Director/Board Member | |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member | |
Nuvisan Oncology SA
Nuvisan Oncology SA Miscellaneous Commercial ServicesCommercial Services Nuvisan Oncology SA is a French company that was founded in 1996. The private company is based in Paris, France. Nuvisan Oncology engages in research and development of physical and natural science. | Miscellaneous Commercial Services | Director/Board Member | |
RAYNOVENT Co., Ltd.
RAYNOVENT Co., Ltd. BiotechnologyHealth Technology RAYNOVENT Co., Ltd. is a Chinese company located in Guangzhou that engages in research, development and commercialization of innovative drugs in the fields of liver & respiratory diseases. | Biotechnology | Corporate Officer/Principal | |
City of Frankfurt am Main (Germany) | Municipality | Chairman |
Estadísticas
Internacional
Alemania | 31 |
Reino Unido | 6 |
China | 6 |
Estados Unidos | 4 |
Suiza | 3 |
Sectorial
Health Technology | 20 |
Consumer Services | 12 |
Commercial Services | 9 |
Finance | 5 |
Technology Services | 3 |
Operativa
Director/Board Member | 31 |
Corporate Officer/Principal | 17 |
Chief Executive Officer | 15 |
Director of Finance/CFO | 10 |
Doctorate Degree | 9 |
Las relaciones más conectadas
Insiders | |
---|---|
Mathias Hothum | 19 |
Peter Llewellyn-Davies | 14 |
Andreas Krebs | 13 |
Thomas Borcholte | 11 |
Andreas Pahl | 9 |
Walter Miller | 8 |
Mathias Locher | 5 |
Dong Zhou Liu | 5 |
Olaf G. Wilhelm | 4 |
Paul Bevan | 3 |
Xu Min Zhao | 3 |
András Strassz | 2 |
George Badescu | 2 |
Jörg Kemkowski | 1 |
- Bolsa de valores
- Insiders
- Jan Schmidt-Brand
- Conexiones Empresas